These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 12902169)
1. Will genomics revolutionise pharmaceutical R&D? Noble D Trends Biotechnol; 2003 Aug; 21(8):333-7. PubMed ID: 12902169 [TBL] [Abstract][Full Text] [Related]
2. Modeling the heart--from genes to cells to the whole organ. Noble D Science; 2002 Mar; 295(5560):1678-82. PubMed ID: 11872832 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Fischer HP Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773 [TBL] [Abstract][Full Text] [Related]
5. The impact of systems approaches on biological problems in drug discovery. Hood L; Perlmutter RM Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453 [No Abstract] [Full Text] [Related]
6. The heart is already working. Noble D Biochem Soc Trans; 2005 Jun; 33(Pt 3):539-42. PubMed ID: 15916559 [TBL] [Abstract][Full Text] [Related]
7. Systems biology and the heart. Noble D Biosystems; 2006; 83(2-3):75-80. PubMed ID: 16233947 [TBL] [Abstract][Full Text] [Related]
9. Carlo Incerti. Incerti C Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428 [No Abstract] [Full Text] [Related]
10. Prescription for an ailing pharmaceutical industry. Demain AL Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826 [No Abstract] [Full Text] [Related]
11. In biomarkers we trust? Baker M Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081 [No Abstract] [Full Text] [Related]
12. From genes to whole organs: connecting biochemistry to physiology. Noble D Novartis Found Symp; 2001; 239():111-23; discussion 123-8, 150-9. PubMed ID: 11529307 [TBL] [Abstract][Full Text] [Related]
13. Systems biology in drug discovery. Butcher EC; Berg EL; Kunkel EJ Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465 [TBL] [Abstract][Full Text] [Related]
14. The end of the beginning for genomic medicine. Bailey D; Zanders E; Dean P Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543 [No Abstract] [Full Text] [Related]
15. siRNAs in drug discovery: target validation and beyond. Natt F Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical futures: a fiendish puzzle. Abbott A Nature; 2008 Oct; 455(7217):1164-7. PubMed ID: 18971993 [No Abstract] [Full Text] [Related]
17. Building with a scaffold: emerging strategies for high- to low-level cellular modeling. Ideker T; Lauffenburger D Trends Biotechnol; 2003 Jun; 21(6):255-62. PubMed ID: 12788545 [TBL] [Abstract][Full Text] [Related]
19. Discovery and development of biomarkers of neurological disease. Dunckley T; Coon KD; Stephan DA Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281 [TBL] [Abstract][Full Text] [Related]
20. The power of genomics to transform the biotechnology industry. Haseltine WA Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259 [No Abstract] [Full Text] [Related] [Next] [New Search]